Insights

The U.S. Food and Drug Administration will hold hearings about stem cell research this month, on Sept. 12-13. In coming months the agency will review ongoing experimental surgeries that the National Institutes of Health has been monitoring.

The cost of chemotherapy constitutes over half of cancer treatment-related costs in the U.S. According to a recent report by the IMS Institute for Healthcare Informatics, the overall cost of cancer care has catapulted since 2011.

Breastfeeding rates have risen in recent years, but big differences remain between states. Here's a look at the latest numbers and why many moms still find it hard to breastfeed.

National Journal seeks an energetic, intellectually curious health care journalist to join their Capitol Hill team.

People living with HIV and the civil society thronged the streets of Mutare as they marched in a bid to present their petition to the Manicaland Provincial Minister Mandi Chimene to see into the Mutare municipality clinic’s consultation fees that were increased ....

Here we check in with prominent health journalists and experts to see what sites, newsletters and social media feeds they turn to first every morning. This week, we caught up with Charles Ornstein, senior reporter for ProPublica.

As the legalization of weed appears imminent in California, former Los Angeles Times reporter Sam Quinones says the crucial question we should be asking is, "What kind of marijuana should we legalize?"

A quick primer on the science of how obesity and high cholesterol can break down cartilage and bones, spurring the development of arthritis.

HIV prevalence has remained a problem among young people across the globe....

A look at how leading media outlets handled a potentially misleading piece of research data in a recent study on the use of gene tests in treating breast cancer.